sickle cell disease
Showing 26 - 50 of 605
Sickle Cell Disease Trial in Vadodara, Nagpur, Pune (NUV001 - IR, NUV001 - GR, Placebo)
Not yet recruiting
- Sickle Cell Disease
- NUV001 - IR
- +2 more
-
Vadodara, Gujarat, India
- +2 more
Mar 17, 2023
Sickle Cell Disease Trial in Marseille (NUV001)
Not yet recruiting
- Sickle Cell Disease
- NUV001
-
Marseille, FranceAphm Hopital La Timone Adultes Sce Medecine Interne (Umap)
Mar 28, 2023
Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)
Recruiting
- Sickle Cell Disease
- +2 more
- HDL2
-
Pointe-à-Pitre, Guadeloupe, France
- +1 more
Mar 21, 2023
Sickle Cell Disease, Multiple Myeloma Trial in Washington
Enrolling by invitation
- Sickle Cell Disease
- Multiple Myeloma
-
Washington, District of ColumbiaASH Research Collaborative
Mar 7, 2023
Sickle Cell Disease Trial (Plant-based omega-3-FA)
Not yet recruiting
- Sickle Cell Disease
- Plant-based omega-3-FA
- (no location specified)
Mar 6, 2023
Arterial Function Parameters and Transcranial Doppler Velocity
Recruiting
- Sickle Cell Disease
-
Kingston, Saint Andrew, JamaicaCaribbean Institute for Health Research, The University of the W
Feb 17, 2023
Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)
Recruiting
- Sickle Cell Disease
- +2 more
- Fludarabine
- +7 more
-
Basking Ridge, New Jersey
- +5 more
Feb 17, 2023
Organ Transplant, Cancer, Inborn Errors of Metabolism Trial (A sphygmanometer, a digital thermometer, a pulse oximeter and a
Not yet recruiting
- Organ Transplant
- +5 more
- A sphygmanometer, a digital thermometer, a pulse oximeter and a peak flow meter will be given to participants to use during their telemedicine consultations with health care providers.
- (no location specified)
Feb 8, 2023
Sickle Cell Disease Trial (Nexplanon 68 MG Drug Implant)
Not yet recruiting
- Sickle Cell Disease
- Nexplanon 68 MG Drug Implant
- (no location specified)
Feb 6, 2023
Sickle Cell Disease Trial in Atlanta (Etavopivat)
Not yet recruiting
- Sickle Cell Disease
-
Atlanta, GeorgiaEmory University Children's Healthcare of Atlanta
Feb 10, 2023
Sickle Cell Disease Trial in Groningen (GBT021601)
Active, not recruiting
- Sickle Cell Disease
-
Groningen, NetherlandsICON Clinical Research Unit
Jan 30, 2023
Sickle Cell Disease Trial (Gerofit Exercise Program)
Not yet recruiting
- Sickle Cell Disease
- Gerofit Exercise Program
- (no location specified)
Jan 30, 2023
Sickle Cell Disease Trial in Worldwide (Hydroxycarbamide, Placebo Oral Tablet)
Recruiting
- Sickle Cell Disease
- Hydroxycarbamide
- Placebo Oral Tablet
-
Abidjan, Côte D'Ivoire
- +20 more
Jan 26, 2023
Human Biospecimens for Basic and Clinical Research Into Globin
Recruiting
- Alpha and Beta Thalassemia
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Sickle Cell Anemia in Children, Sickle Cell Disease Trial in Luanda (Hydroxyurea)
Not yet recruiting
- Sickle Cell Anemia in Children
- Sickle Cell Disease
-
Luanda, AngolaHospital Geral dos Cajueiros
Jan 26, 2023
Secondary Pulmonary Hypertension in Sickle Cell Anemia
Completed
- Pulmonary Hypertension
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Sickle Cell Disease, Hemolytic Anemia Trial run by the NHLBI (Mitapivat)
Active, not recruiting
- Sickle Cell Disease
- Hemolytic Anemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Baby Detect : Genomic Newborn Screening
Recruiting
- Congenital Adrenal Hyperplasia
- +126 more
-
Liege, Wallonia, BelgiumCRMN, Hôpital La Citadelle
Jan 24, 2023
Certain Diseases Involving Blood Vessels
Recruiting
- Sickle Cell Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Storage of Umbilical Cord Stem Cells for Treatment of Sickle
Recruiting
- Sickle Cell Disease
- Sickle Cell Trait
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral
Recruiting
- Congenital Hemolytic Anemia
- Sickle Cell Disease
- Peripheral blood hematopoietic progenitor cell (PBPC) transplant
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Sickle Cell Disease Trial in Adana, Mersin (NDec - oral decitabine-tetrahydrouridine, HU - Hydroxyurea, Placebo)
Recruiting
- Sickle Cell Disease
- NDec - oral decitabine-tetrahydrouridine
- +2 more
-
Oakland, California
- +39 more
Jan 24, 2023
Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)
Recruiting
- Sickle Cell Disease
- +4 more
- CTX001
-
Philadelphia, Pennsylvania
- +3 more
Jan 24, 2023
Sickle Cell Disease Trial in Worldwide (VIT-2763 120 mg, VIT-2763 360 mg, VIT-2763 240 mg)
Recruiting
- Sickle Cell Disease
- VIT-2763 120 mg
- +4 more
-
Birmingham, Alabama
- +12 more
Jan 20, 2023